134 participants were randomly allocated to the FOLFOX group and 133 to the fluorouracil and cisplatin group ( intention-to-treat population ) , and 131 patients in the FOLFOX group and 128 in the fluorouracil and cisplatin group actually received the study drugs ( safety population ) .